PWD are even more susceptible because combining any one of these variables with even slightly high blood sugar levels creates an easy environment for the overgrowth of yeast
Sekhar RV, Patel SG, Guthikonda AP, et al
Wegovy is part of a class of drugs called GLP-1 Receptor Agonists that help people increase the amount of insulin in their body to lower the amount of sugar in their blood
Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials
doi: 10.15381/ci.v12i1.3387
This is similar to whats reported in FDA data, which shows the most common side effect, nausea, happens in 44% of people on Wegovy (compared to 16% of people on a placebo)